Ticker brief
TECX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
2
crowd 14d
+0.33
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-18 → 2026-08-27 · now +0.40 (−1 bearish … +1 bullish)
Who spoke2
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @semodough | C | -3.01 | 4 | +0.34 |
| @Brad_E_Schulz | C | · | 2 | +0.50 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @semodough | +0.40 | Mizuho reiterates Outperform with an $85 target while previewing September TX2100 Phase 1a results. | · | tweet ↗ |
| 2026-08-25 | @semodough | +0.55 | Expects positive AZN trial results to validate TECX's related long-acting injectable program. | · | tweet ↗ |
| 2026-08-23 | @semodough | +0.00 | Flags four biotech names for a busy upcoming ESC26 week without stating a directional view. | · | tweet ↗ |
| 2026-08-18 | @Brad_E_Schulz | +0.50 | Quantifies daily sector breadth and performance, led by bio/pharma while semiconductors lag. | · | tweet ↗ |
| 2026-08-18 | @Brad_E_Schulz | +0.50 | Lists intraday gainers up at least 4% on at least 1.5 times average volume. | · | tweet ↗ |
| 2026-08-18 | @semodough | +0.40 | Cowen sees positive AstraZeneca relaxin data as potentially de-risking Tectonic's TX45 program. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.